The first edition of PharmaProcess gathers speakers and employers leaders of the pharmaceutical sector

PharmaProcess analyses the questions that centre the debate in the industry of the processes of the medicine to world-wide level. With the participation of 55 national west and international, 150 congressmen, more than 600 professional visitors and 50 display units, the fair has settled like an appointment inaludible. The forum, the first that celebrates in Europe of this thematic, takes place the days 29 and 30 October in the Palau of Congressos of the enclosure of Montjuïc of Fira of Barcelona.

PharmaProcess Is the forum of world-wide innovations of the Pharmaceutical Industry, Biofarmacéutica and of the Sciences of the Life that endows to the professionals of the sector of greater capacities in front of the innovations of the market.

The act of inauguration of PharmaProcess had the participation of stood out professionals of the sector, as well as of Andreu Mas-Colell, Conseller d'Economia i Coneixement of the Government of Catalonia. But Colell showed his support to “initiatives so important like PharmaProcess” and signalled that “Catalonia represents the pharmaceutical industry of Spain and there is not better place where receive characters so important inside the international sector”. In this line, the director of the living room, Pilar Navarró, aimed that “Fira of Barcelona has designed a forum that gives answer to the interests and needs of a sector that precise of scientific knowledge, networking and opportunities of business”.

Act of inauguration of PharmaProcess.

The speakers of the forum will debate, between other questions, leftover the suitability of the use of medicines caducados or the form to warn the distribution and sale of false medicines, what supposes a big risk for the health. Eduardo Pisanni, general director of the International Federation of Pharmaceutical Manufacturers and Associations, aimed that “the fake is destroying a lot of investigations and, in consequence, innovations by fault of economic resources. At present, we are spending more money that never in spite of the international crisis reason believe firmly that support the development biomédico is to support the public health and struggle by a healthier world for all”. In this way, Pisanni affirmed his wish to turn into “an agent of change that offer medicines to all the society”.

Of left to right: Andreu Mas-Colell, Conseller d'Economia i coneixement of the Government of Catalonia; Ton Capella, president of the Committee Organiser and president and adviser delegated of Azbil Telstar; Gisele Roesems, boss of the Unit of Health and Welfare of the European Commission and Eduardo Pisani, general director of the International Federation of Pharmaceutical Manufacturers and Associations.

Likewise, and in a context in that the emergent countries also are turning into poles of innovation, PharmaProcess tackles the differences between the existent rules for the manufacture of active principles all over the world that allow that countries like China or Indian are the main producing countries in this moment.

PharmaProcess vertebra Around 3 axles; Development, that covers the process that goes from the first formulation until the phase of industrialisation of the medicine; Biopharmatech, where tackle the novelties of the new pharmaceutical products been cream of the biotechnology; and Operations, track that treats questions related with the manufacture and distribution of medicines.

Each one of them has the participation of speakers of world-wide reference, between which stand out the Catalan doctor settled in United States Jordi Barretina, one of the most prestigious specialists in the investigation of medicines biotecnológicos against the cancer; Martin Friedrich, director of Authentication and Follow-up of Medicines of Bayer; Pierre Monsan, director of the Laboratory of Biotechnology of Tolouse, or Gisele Roesems, boss of the Unit of Health and Welfare of the European Commission.

This last exposed in the act of inauguration that “the pharmaceutical industry has a lot of opportunities and applications in a big number of sectors, but his main aim has to be always the general health of the population”. Roesems Explained some of the European initiatives related with the health and the welfare, which base in “giving the power to the patient to control his health and his illness”. To attain it, the European Commission pleads for the education, as it exposed Roesems: “through the information to the citizen will achieve that this learn to do a good use of the medicines and take care his health of efficient form”.

PharmaProcess Has a zone of exhibitions in that 50 companies of the sector expose his novelties for the improvement of the industrial processes in the manufacture of medicines. Besides, it has designed an attractor trucks program of activities for visitors and display units. It treats of a diary of visits programmed and commented to three big scientific installations of Barcelona; The BCN Supercomputering Center, the Parc of Recerca Biomédica of Barcelona and the sincrotrón ALBA.